Company / Operating Cash Flow
Evolent Health, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$38.8M
FY2025
5-year range
-$11.6M / $142.6M
FY2021-FY2025
Trend
+107.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$43M in FY2019 to $143M in FY2023.
Based on SEC 10-K filings.
$39M in FY2025.
Declined from $143M to $39M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 107.0% year-over-year.
- Peak operating cash flow was recorded in FY2023.
- Lowest operating cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.8M | +107.0% |
| FY2024 | $18.8M | -86.8% |
| FY2023 | $142.6M | +1334.2% |
| FY2022 | -$11.6M | -129.8% |
| FY2021 | $38.7M | +338.8% |
| FY2020 | -$16.2M | +62.0% |
| FY2019 | -$42.6M | -106.5% |
| FY2018 | -$20.7M | +26.1% |
| FY2017 | -$28.0M | +21.3% |
| FY2016 | -$35.5M | -92.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026